series-a
Stage
1
Investors
About
CONNECTA Therapeutics is a clinical-stage biotechnology company developing innovative neuroplasticity modulator therapies focused on treating central nervous system disorders, including neurodevelopmental diseases such as Fragile X Syndrome.
Explore CONNECTA Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.